Kain Cosmeceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 17-06-2024
- Paid Up Capital ₹ 1.20 M
as on 17-06-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.00 Cr
as on 17-06-2024
- Revenue %
(FY 2022)
- Profit -436.14%
(FY 2022)
- Ebitda -436.82%
(FY 2022)
- Net Worth -117.05%
(FY 2022)
- Total Assets 299.77%
(FY 2022)
About Kain Cosmeceuticals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹32.00 Cr.
Nishit Dedhia, Kartik Kingrani, Jinit Dedhia, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2019PTC333084
- Company No.
333084
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kain Cosmeceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Chandrabhan  | Director | 22-Mar-2022 | Current |
| Kartik Kingrani | Director | 22-Mar-2022 | Current |
| Nishit Dedhia | Director | 16-Nov-2019 | Current |
| Jinit Dedhia | Director | 14-Jan-2020 | Current |
Financial Performance of Kain Cosmeceuticals.
Kain Cosmeceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 436.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 117.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kain Cosmeceuticals?
In 2022, Kain Cosmeceuticals had a promoter holding of 33.33% and a public holding of 66.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innovative Pharmaceuticals Private LimitedActive 4 years 5 monthsRajesh Chandrabhan is a mutual person
Searle Remedies LimitedActive 12 years 6 monthsKartik Kingrani and Rajesh Chandrabhan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Nov 2022 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Aug 2022 | ₹15.00 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Aug 2022 | ₹15.00 Cr | Open |
How Many Employees Work at Kain Cosmeceuticals?
Unlock and access historical data on people associated with Kain Cosmeceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kain Cosmeceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kain Cosmeceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
